Evofem Biosciences, Inc. (EVFM)
0.0071
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Evofem Biosciences Debt to Equity Ratio : -0.6586 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6586 |
| March 31, 2026 | -0.7214 |
| December 31, 2025 | -0.7856 |
| September 30, 2025 | -0.7431 |
| June 30, 2025 | -0.7298 |
| March 31, 2025 | -0.7056 |
| December 31, 2024 | -0.6915 |
| September 30, 2024 | -0.6771 |
| June 30, 2024 | -0.6715 |
| March 31, 2024 | -0.6424 |
| December 31, 2023 | -0.7005 |
| September 30, 2023 | -0.7557 |
| June 30, 2023 | -0.776 |
| March 31, 2023 | -0.9839 |
| December 31, 2022 | -0.9906 |
| September 30, 2022 | -1.073 |
| June 30, 2022 | -0.5821 |
| March 31, 2022 | -0.971 |
| December 31, 2021 | -1.162 |
| September 30, 2021 | -1.744 |
| June 30, 2021 | 8.718 |
| March 31, 2021 | -6.377 |
| December 31, 2020 | 63.80 |
| September 30, 2020 | 1.398 |
| June 30, 2020 | 0.723 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.2605 |
| December 31, 2019 | 0.0126 |
| September 30, 2019 | 0.0159 |
| June 30, 2019 | 0.0162 |
| March 31, 2019 | -0.1657 |
| December 31, 2018 | -0.1717 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.2494 |
| March 31, 2016 | 0.2129 |
| December 31, 2015 | 0.4184 |
| September 30, 2015 | 0.3026 |
| June 30, 2015 | 0.1986 |
| March 31, 2015 | 0.1669 |
| December 31, 2014 | 0.1493 |
| September 30, 2014 | 0.5815 |
| December 31, 2013 | 0.2598 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 7.522M |
| Total Liabilities (Quarterly) | 90.01M |
| Shareholders Equity (Quarterly) | -82.49M |
| Current Ratio | 0.0686 |
| Net Debt Paydown Yield | -162.8% |